(17314293), C. R., (21632380), A. O., (21632383), C. M., (15331351), R. B., (21468025), D. J., (16494599), C. S., . . . (15055771), P. K. P. (2025). Figure 1 from Liquid and Tissue Biopsies for Identifying <i>MET</i> Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib.
Цитирование в стиле Чикаго (17-е изд.)(17314293), Christian Rolfo, Aurora O’Brate (21632380), Christoph Menzel (21632383), Rolf Bruns (15331351), Dilafruz Juraeva (21468025), Christopher Stroh (16494599), Andreas Johne (15331354), и Paul K. Paik (15055771). Figure 1 from Liquid and Tissue Biopsies for Identifying <i>MET</i> Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib. 2025.
Цитирование MLA (9-е изд.)(17314293), Christian Rolfo, et al. Figure 1 from Liquid and Tissue Biopsies for Identifying <i>MET</i> Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib. 2025.